Germany Adjusts Drug Pricing Reform After Pharmaceutical Investment Pullback

Germany is reportedly modifying its proposed healthcare reforms, specifically concerning drug pricing. This adjustment follows significant investment withdrawals by major pharmaceutical companies in response to earlier plans for variable medicine discounts. The government now aims to introduce fixed price reductions to offer greater predictability for drug manufacturers and address industry concerns.